Development of sweet potato (Ipomoea batatas Lamk.) as excipient in tablet formulation by Mahalia, Lamia Diang et al.
                                Journal of Public Health Research 2020; volume 9:1831
Development of sweet potato (Ipomoea batatas Lamk.) as excipient in
tablet formulation
Lamia Diang Mahalia,1 Stefanus Supriyanto,2 Yandi Syukri3 
1Doctoral Program of Public Health, Faculty of Public Health; 2Departement of Health Policy and
Administration, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia; 3Departement of
Pharmacy, Faculty of Mathematic and Science, Universitas Islam Indonesia, Yogyakarta, Indonesia
Abstract
Background: Sweet potato has a potential to be used as a raw
material for tablets. However, it needs chemical modifications to
produce derivatives with excellent pharmaceutical characteristics.
The primary purpose of this research was to use sweet potato
starch (Ipomoea batatas Lamk.) as a tablet excipient modified
through a chemical process. 
Design and Methods: This study is experimental and is divid-
ed into three stages. The first stage is the extraction process to
obtain sweet potato starch. The second stage is the chemical mod-
ification of sweet potato starch using pentanol-1 and glacial acetic
acid. The third step is the analysis of the pharmaceutical properties
of the mutated lab model compared to the control sample and
Amprotab. 
Results: The descriptive-comparative analysis showed sweet
potato starch modified with panthenol-1 had a higher hardness
value (=2.55±0.34) compared to native starch (1.00±0.08). The
particle size distribution of the modified sample with acetate acid
(=15.20±1.79) was higher than the others. 
Conclusions: In conclusion, modified sweet potato starch has
better pharmaceutical properties than native starch. Further
research needs to be conducted on the magnitude of the potential
of sweet potato starch as an excipient, both as filler, a binder, and
a crushing agent on tablet preparations.
Introduction
The majority of the pharmaceutical industry in Indonesia is
limited in the industrial manufacture of finished drugs. This caus-
es the rise in demand for imported raw materials for medicines,
where almost 90% is imported, with a large bulk originating from
China, India, and Europe.1 The high dependence on imported raw
materials makes the Indonesian pharmaceutical industry very vul-
nerable, especially with the weakening of the rupiah, which
increases production cost.1 The industry needs to transform, not
only as a formulation but also in the future, being able to be based
on research, development, and manufacturing, producing raw
materials independently.1 Physical and chemical modified starch
is a medicinal ingredient still imported in Indonesia. In various
countries such as India, China, and New Zealand, the starch mod-
ification effort has been excellent to produce various derivatives
with diverse characteristics suiting their functions in pharmacy.2-4
Several studies examined the potential of various tropical starch
from local Indonesian bulbs, especially sweet potato. Excipients
and other active components are usually added to tablet formula-
tions. 5-7 There are non active ingredients that can be directly com-
pressed into tablets without excipients.8
Starch from local sweet potato needs a chemical modification
process to produce derivatives with better specific pharmaceutical
characteristics. The modification include the use of sodium tri
polyphosphate8 and sodium acetate.9 Therefore, this research aims
to utilize local Indonesian plants, such as sweet potatoes, to devel-
op raw pharmaceutical materials. Sweet potato was chemically
modified using pentanol-1 and glacial acetic acid to improve its
pharmaceutical properties for the production of tablets.
Design and Methods
This research is experimental. It is divided into three stages.
The sweet potato varieties at hand were determined in biology lab-
oratories. The stages then involved the extraction process to obtain
sweet potato starch and the chemical modification of the starch
using pentanol-1 and glacial acetic acid. The alteration was
obtained by mixing 125 ml of pentanol-1 into 125 g of unmodified
starch, then blending for 30 minutes at room temperature. The
blend is further mixed with 375 ml of aquadest and dissolved.
Thereafter, 8 ml of glacial acetic acid is added to the solution and
heated to 45°C for 60 minutes stirring. The residue after filtration
was washed with aquadest four times. The precipitate was dried in
the oven and mashed using a sieve. The third and final step is the
analysis of the pharmaceutical properties of mutated and unmodi-
fied sweet potato starch and amprotab using a comparative
descriptive method. It included: organoleptic, microscopic, solu-
bility, iodine identification, particle size, powder flow properties,
tapping test, and compactibility.
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Based on the particle size test on the three types of sweet pota-
to starch and Amprotab, the average result was set out in Table 1.
Flow time tests on chemically modified and control starch shows
lack of flow time. Based on the tapping test on three types, the
average index obtained is shown in Table 2. Table 3 shows the
average values obtained based on the compatibility test. The
organoleptic examination shows chemically modified sweet potato
starch is a fine powder with white color and no taste or smell.
Furthermore, there was no significant difference between the mod-
ified sample, the remaining unmodified sample and Amprotab.
Microscopic examination showed a single-grained and spherical
chemically modified sweet potato starch with a hilus in the middle
of the particle. Dissolution in aquadest was meant to test the solu-
bility of the sample, and the results showed it did not dissolve in
water. Sweet potato starch and Amprotab produce purple and dark
blue colors in Iodine with a similarity in the particles analysis.
Organoleptic examination
This test was carried out to determine the shape, color, smell,
and taste. The results show the two types of chemical modified
sweet potato starch are in form of fine powders and white color.
The same was observed for Amprotab and the unmodified sam-
ple.10
Microscopic examination
A x40 magnification showed the chemically modified sweet
potato starch was spherical shape, and appeared as a single grain
with a hilus in the middle of the particle. The results remained con-
stant when the same test was carried out to compare with unmodi-
fied starch and Amprotab.10
Solubility examination
Chemical modified sweet potato starch was dissolved in
aquadest. The results show no solubility in water. The same test
findings were reached with the remaining sample materials.
According to Rowe et al., starch is insoluble in water11,12 since it
contains large amounts of amylopectin, which is insoluble.13
Iodine identification
The sweet potato starch produce purple color while Amprotab
showed dark blue pigments.  This is attributed to the larger
amounts of amylopectin than amylose in its composition.
However, Amprotab’s composition shows contrary results with
more amylose.13 The formation of a purplish-blue color is due to
the reaction of amylose and iodine forming a complex substance,
while the amylopectin from starch turns a bluish or violet color.14
Particle size analysis
The results indicated similar sizes for the test sample material.
According to Indonesian Pharmacopoeia, the microscopic exami-
nation results of starch diameter is 5-10µm and 20-35µm for small
and large grains, respectively.10 The size of particles affects the
physical and chemical properties of the drug, including the rate of
dissolution, texture, and homogeneity.15 Sweet potato starch and
Amprotab have a small and excellent particle size, which causes
variations in the weight of the tablet. Starches with particle sizes
that are too small affect the uniformity of the tablet contents.16
Powder flow properties test
This test is based on flow time and stationary angle.14 Good
flow speed requirements are >10 g/sec (free-flowing) and 4-10
g/sec (easy flowing).15 The test showed that all the sample material
do not have flow time, which means they have poor movement
properties. This condition is attributed to their small and fine par-
ticle size, which increases their cohesion power and slow down the
powder flow. Good fixed angle value of starch is 20o-40o, and
above 50o, the flow presents difficulties, and might even be impos-
sible.15 Several factors influence the stationary angle, including the
tensile and frictional forces between particles. The angle is nar-
rowed if the magnitude of the factors is reduced.17 Without the
flow time, the stationary angle cannot be measured; hence the
starches were declared not to meet the requirements of good flow
properties.
Tapping test
The test shows a decrease in the volume of granules due to
pounding and vibration. Generally, a smaller tapping index (%)
makes the flow properties better. A small compressibility value
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Table 1. Particle size test on the three types of sweet potato starch
and Amprotab.
No.   Type of starch                                                    Particle size
                                                                                  average (µm)
1.         Unmodified starch                                                                        15.80
2.         Modified starch using pentanol-1                                             12.90
3.         Modified starch using glacial acetic acid                                 15.20
4.         Amprotab                                                                                        18.25
Table 2. Tapping test on the three types of sweet potato starch and
Amprotab.
No.   Type of starch                                                Average tapping 
                                                                                      index (%)
1.         Unmodified starch                                                                         20.6
2.         Modified starch using pentanol-1                                              24.6
3.         Modified starch using glacial acetic acid                                  28.0
4.         Amprotab                                                                                         15.4
Table 3. Compatibility test on the three types of sweet potato starch and Amprotab.
No.      Type of starch                                                                                               Hardness scale
                                                                                         5                                                    6                                                     7
                                                                    Average of compactibility           Average of compactibility           Average of compactibility
1.             Unmodified starch                                                                  -                                                                 0.56                                                               1.00
2.             Modified starch using pentanol-1                                    0.62                                                              1.04                                                               2.55
3.             Modified starch using glacial acetic acid                        0.59                                                              0.84                                                               2.01
4.             Amprotab                                                                                0.72                                                              1.53                                                               4.52










shows the granules organize themselves for tapping, leading to
volume reduction.18,19 Essentially, powders with a tapping index
lower than 20% have good flow properties.20 The results in Table
2 show the average tapping index of all sweet potato starch is more
than 20%. And, is in contrast from Amprotab’s with an index of
less than 20%. This shows that sweet potato starch has poor com-
pressibility.
Compatibility test
This test was meant to determine the ability of the powder to
form a compact mass. In general, the size of particles affects the
compactness of the tablet when printing. Small-sized and fine
powder fills the printing space well.16,21,22 In this experiment,
sweet potato starch was modified using pentanol-1, glacial acetic
acid, and Amprotab to form tablets on a hardness scale of 5, 6, and
7. Unmodified starch only forms tablets on a hardness scale of 6
and 7, showing that modified starch is more compact.
Conclusions
The physio-chemical characteristics of laboratory modified
sweet potato starch show the same features of Amprotabs.
However, mutated sweet potato and Amprotab have equal compat-
ibility strengths. Overall, modified sweet potato starch has better
pharmaceutical properties. Further research needs to be conducted
on the magnitude of the potential of sweet potato starch as an
excipient, both as a filler, a binder, and a crushing agent on tablet
preparations.
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